Gabelli Funds LLC Axogen, Inc. Transaction History

Gabelli Funds LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$8.5 - $10.38 $34,000 - $41,520	4,000 Added 4.08%	101,970 $930,000
Q3 2022 Nov 10, 2022	SELL	$8.14 - $12.25 $162,800 - $245,000	-20,000 Reduced 16.95%	97,970 $1.17 Million
Q1 2022 May 13, 2022	BUY	$7.26 - $10.7 $60,381 - $88,991	8,317 Added 7.58%	117,970 $937,000
Q4 2021 Feb 11, 2022	BUY	$8.8 - $16.0 $354,736 - $644,976	40,311 Added 58.13%	109,653 $1.03 Million
Q3 2021 Nov 12, 2021	BUY	$15.23 - $21.72 $121,840 - $173,760	8,000 Added 13.04%	69,342 $1.1 Million
Q2 2021 Aug 13, 2021	BUY	$17.8 - $23.5 $53,400 - $70,500	3,000 Added 5.14%	61,342 $1.33 Million
Q1 2021 May 14, 2021	BUY	$17.18 - $22.6 $229,353 - $301,710	13,350 Added 29.67%	58,342 $1.18 Million
Q1 2020 May 14, 2020	BUY	$8.38 - $17.34 $149,960 - $310,299	17,895 Added 66.04%	44,992 $468,000
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $22,360 - $37,200	2,000 Added 7.97%	27,097 $485,000
Q3 2019 Nov 01, 2019	BUY	$12.09 - $20.46 $303,422 - $513,484	25,097 New	25,097 $313,000
Q2 2019 Aug 02, 2019	SELL	$18.5 - $25.47 $177,600 - $244,512	-9,600 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$14.62 - $22.13 $140,352 - $212,448	9,600 New	9,600 $202,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.